유럽 ​​원격 환자 모니터링 시장 – 2023-2030

Europe Remote Patient Monitoring Market - 2023-2030

상품코드MD6324
발행기관DataM Intelligence
발행일2023.03.28
페이지 수200 Pages
포맷PDF + EXCEL
커버리지Europe

₩5,625,000 – ₩10,875,000

보고서 요약(국문)

시장 개요
유럽의 원격 환자 모니터링(RPM) 시장 규모는 2022년 143억 189만 달러였으며, 예측 기간(2023~2030년) 동안 연평균 14.1% 성장하여 398억 4,726만 달러에 이를 것으로 예상됩니다.
원격 환자 모니터링은 기존 의료 환경을 넘어 환자 데이터를 수집하기 위해 정보 기술의 발전을 활용하는 의료 서비스 제공 방식입니다. RPM은 환자가 자신의 건강 관리에 더욱 적극적으로 참여하고 책임감을 갖도록 함으로써 환자 행동 변화를 유도합니다. 특히 일부 지역에서는 의료 서비스 접근에 어려움을 겪는 환자들이 있는데, 원격 환자 모니터링은 의료진이 더 많은 환자를 치료할 수 있도록 지원합니다.
시장 동향
원격 환자 모니터링 기술의 발전, 우호적인 규제, 고령 인구 증가, 그리고 연령 관련 만성 질환 사례 증가는 예측 기간 동안 유럽 원격 환자 모니터링 시장 성장을 촉진할 것으로 예상됩니다.
유럽 지역의 시장 개발이 활발해짐에 따라 유럽 시장 성장이 더욱 가속화될 것으로 전망됩니다.

제품 출시, 협력, 파트너십 등과 같은 시장 개발 동향이 예측 기간 동안 유럽 원격 환자 모니터링 시장의 성장을 견인하고 있습니다. 예를 들어, 원격 의료 및 원격 환자 모니터링 솔루션 헬스케어 기술 기업인 eDevice SA는 2021년 6월 보스턴 사이언티픽의 첨단 원격 심장 모니터링 시스템인 TwoCan Pulse의 프랑스 유통권을 획득했으며, eDevice는 프랑스 시장에서 이 혁신적인 제품을 최초로 도입했습니다. 마찬가지로, 2021년 6월 MicroPort CRM은 SmartView Connect 홈 모니터와 연동하여 원격 모니터링이 용이한 블루투스 기술이 적용된 Alizea 및 Borea 심박 조율기를 유럽에 출시했습니다. 이 심박 조율기를 통해 심장 전문의는 원격으로 기기를 모니터링할 수 있어 환자들이 간단한 정기 검진을 위해 의료 시설을 방문해야 하는 번거로움을 줄이고 의료 시스템의 부담을 완화할 수 있습니다. 또한, 2021년 4월 Smith+Nephew와 Huma는 영국에서 정형외과 수술 환자를 위한 원격 모니터링 서비스 확대를 위해 협력했습니다. 또한, 2022년 1월 오므론 헬스케어(OMRON Healthcare, Inc.)는 영국에서 고혈압 플러스(Hypertension Plus)를 출시했습니다. 이 새로운 원격 환자 모니터링 서비스는 연결된 혈압계와 최첨단 모바일 앱을 제공합니다.
더욱이, 2022년 4월 에세이(Eseye)는 영국에서 텔리 헬스(Telli Health)의 혁신적인 원격 환자 모니터링(RPM) 기기 제품군(체온계, 맥박 산소 측정기, 혈압계, 혈당 측정기 등)을 선보였습니다. 더불어, 2020년 4월에는 중환자실(ICU) 확충을 위한 신속 장비 배포 키트(Rapid Equipment Deployment Kit)를 출시하여 기술자, 간호사, 의사 및 병원 직원이 코로나19 팬데믹 상황에서 중환자 모니터링 역량을 신속하게 강화할 수 있도록 지원했습니다. 따라서, 이러한 자료들을 종합해 볼 때, 시장 발전이 예측 기간 동안 유럽 원격 환자 모니터링 시장의 성장을 견인할 것으로 예상됩니다.

그러나 원격 환자 모니터링에 대한 윤리적 우려는 유럽 원격 환자 모니터링 시장의 성장을 저해하는 요인으로 작용할 것으로 보입니다.

윤리적 우려는 예측 기간 동안 유럽 원격 환자 모니터링 시장의 성장을 제약하는 요인으로 작용할 것으로 예상됩니다. 예를 들어, 원격 모니터링에 수반되는 대량의 건강 데이터 수집, 전송 및 저장에는 개인 정보 보호 및 데이터 보안 문제를 신중하게 고려해야 합니다. 임상적 유용성과 개인 정보 보호 사이의 균형을 적절히 맞추는 것은 환자의 원격 모니터링에 대한 신뢰를 떨어뜨릴 수 있으며, 의료진에게 윤리적 및 법의학적 위험을 초래할 수 있습니다. 따라서 이는 예측 기간 동안 시장 성장을 저해하는 요인이 될 수 있습니다.
COVID-19의 영향
COVID-19 팬데믹은 이미 인력 부족과 과부하 상태였던 의료 시스템에 엄청난 압력을 가했습니다. 인공호흡기와 같은 환자 모니터링 기술은 중증 COVID-19 환자 모니터링에 도움을 주어 생리적 예비력을 측정하고 팬데믹 기간 동안 치료 개입의 효과를 밝혀내면서 시장에 긍정적인 영향을 미쳤습니다. 또한, 기업들은 필수 의료 장비 제품의 생산을 늘렸습니다. 예를 들어, 2020년 3월, 로열 필립스는 COVID-19 환자를 식별하고 치료하기 위한 중환자 치료 제품 및 솔루션 생산을 확대했습니다. 환자 중증도 모니터, 비침습적 및 침습적 인공호흡을 위한 의료 소모품, 호흡기 질환 치료용 휴대용 인공호흡기 등이 제품 라인에 포함됩니다.
세그먼트 분석
당뇨병 환자 원격 모니터링 부문은 예측 기간(2023-2030년) 동안 유럽 원격 환자 모니터링 시장을 주도할 것으로 예상됩니다.
유럽의 고령 인구와 당뇨병 환자 수가 증가함에 따라 당뇨병 환자 원격 모니터링 부문이 예측 기간 내내 유럽 원격 환자 모니터링 시장을 지배할 것으로 전망됩니다. 예를 들어, 유로스타트(Eurostat)에 따르면 2021년 EU 인구의 20.8%가 65세 이상이었으며, 80세 이상 인구 비율도 상당했습니다. EU의 고령 인구 비율은 2021년 6.0%에서 2100년 14.6%로 2.5배 증가할 것으로 예상됩니다. 또한 세계경제포럼(WEF)에 따르면 유럽연합을 비롯한 전 세계 여러 지역에서 이번 세기에 급속한 고령화 현상이 나타날 것으로 전망됩니다. 2100년까지 EU 인구의 30%가 65세 이상이 될 것으로 예측됩니다. 2021년 EU의 부양비는 32였는데, 2100년에는 57에 이를 것으로 예상됩니다. 즉, 근로 가능 인구 100명당 노인 57명이 있다는 뜻입니다.
또한, 유럽의 당뇨병 환자 증가 추세도 예측 기간 동안 시장 성장을 촉진하고 있습니다. 예를 들어, IDF 당뇨병 아틀라스에 따르면 2021년 IDF 유럽 지역에는 약 6,100만 명의 성인이 당뇨병을 앓고 있었으며, 특히 청소년 및 아동 제1형 당뇨병 환자 수가 약 29만 5천 명으로 가장 많았습니다. WHO 유럽 사무소에 따르면 당뇨병은 5,200만 명 이상의 사람들에게 영향을 미치고 있으며, 여러 유럽 국가에서 당뇨병 유병률은 계속 증가하고 있습니다. 이러한 유럽 지역의 당뇨병 원격 모니터링 시장 발전은 예측 기간 동안 유럽 당뇨병 원격 모니터링 시장의 성장을 견인할 것으로 예상됩니다. 지리적 분석
독일은 유럽 원격 환자 모니터링 시장의 대부분을 차지할 것으로 예상됩니다.
미국 당뇨병 협회에 따르면, 과체중인 사람은 제2형 당뇨병, 심장병, 뇌졸중 발병 위험이 높습니다. 또한 당뇨병, 심혈관 질환, 폐 질환과 같은 만성 비전염성 질환의 위험도 증가합니다. 따라서 독일에서 과체중 인구와 고령 인구가 증가함에 따라 예측 기간 동안 이 지역의 시장이 높은 연평균 성장률(CAGR)로 성장할 것으로 예상됩니다. 예를 들어, 독일 통계청(Destatis)의 추산에 따르면, 독일의 은퇴 연령(67세 이상) 인구는 2030년대 중반까지 약 400만 명 증가하여 최소 2천만 명에 이를 것으로 예상됩니다. 80세 이상 인구는 2030년대 중반까지 580만 명에서 670만 명 사이로 비교적 안정적으로 유지될 것으로 전망됩니다. 또한, 연방 보건부 산하 연방 연구기관인 로베르트 코흐 연구소에 따르면 독일 남성의 3분의 2(67%)와 여성의 절반(53%)이 과체중입니다. 성인의 4분의 1(남성 23%, 여성 24%)은 심각한 과체중(비만)입니다. 따라서 증가하는 노령 인구와 비만 인구는 예측 기간 동안 독일의 시장 지배력을 보장할 것입니다. 위의 데이터를 바탕으로 독일이 예측 기간 동안 유럽 원격 환자 모니터링 시장의 대부분을 차지할 것으로 예상됩니다.

경쟁 환경
유럽 원격 환자 모니터링 시장은 수요 증가와 신규 시장 참여자들의 등장으로 경쟁이 치열합니다. 유럽 ​​원격 환자 모니터링 시장의 주요 업체로는 Abbott Laboratories, GE Healthcare, Medtronic, Masimo Corporation, Boston Scientific, Omron Healthcare, Hill-Rom Services, Inc, BIOTRONIK, Inc., Nihon Kohden Corporation, Koninklijke Philips N.V. 등이 있으며, 이들 업체가 시장 점유율의 대부분을 차지하고 있습니다. 주요 업체들은 신제품 출시, 인수합병, 파트너십, 협력 등 다양한 전략을 통해 유럽 원격 환자 모니터링 시장의 성장에 기여하고 있습니다. 예를 들어, GE Healthcare는 2020년 4월 COVID-19 환자 치료에 있어 의료진과 의료 시스템을 지원하는 새로운 소프트웨어 솔루션을 출시했습니다.
Medtronic plc.

개요:
Medtronic plc는 아일랜드에 본사를 둔 미국 의료기기 회사입니다. 1949년에 설립되었으며, 미국 미네소타주 미니애폴리스에 본사를 두고 있습니다. 메드트로닉은 최소 침습 치료 그룹, 당뇨병 그룹, 재활 치료 그룹, 심장 및 혈관 그룹의 네 가지 사업 부문을 운영하고 있습니다.
제품 포트폴리오:
메드트로닉 PLC의 원격 환자 모니터링 제품 포트폴리오에는 Nellcor 맥박 산소 측정기가 포함되어 있습니다. OxiMax 기술이 적용된 Nellcor 맥박 산소 측정 시스템은 일상적인 임상 환경부터 특별한 상황에 이르기까지 환자 안전 모니터링에 새로운 이정표를 세웠습니다.
유럽 원격 환자 모니터링 보고서는 약 40개 이상의 시장 데이터 표, 45개 이상의 그림, 그리고 약 200페이지 분량의 자료를 제공합니다.

보고서 요약(영어 원문)

Market Overview
Europe’s remote patient monitoring size was valued at US$ 14,301.89 million in 2022 and is estimated to reach US$ 39,847.26 million, growing at a CAGR of 14.1% during the forecast period (2023-2030).
Remote patient monitoring is a healthcare delivery process that employs information technology advances to collect patient data beyond conventional healthcare environments. RPM enhances patient conduct by completing a system by which individuals are more involved and accountable for their health. Moreover, it is challenging for some patients to access caregivers in some provinces. Therefore, remote patient monitoring enriches the capacity of physicians to treat more patients.
Market Dynamics
The growing advancements in remote patient monitoring, favorable regulations, increasing geriatric population, and age-associated chronic disease cases are boosting the European remote patient monitoring market during the forecast period.
The increasing market developments in Europe regions are predicted to drive Europe’s market growth.
The growing market developments such as product launches, collaborations, partnerships, and others are driving the Europe remote patient monitoring market during the forecast period. For example, in June 2021, eDevice SA, a telemedicine and remote patient monitoring solutions healthcare technology company, accepted the distribution of Boston Scientific's TwoCan Pulse in France, an advanced telecardiology monitoring system, and eDevice has been the innovator of this innovation in the French market. Similarly, in June 2021, MicroPort CRM introduced Alizea and Borea pacemakers in Europe, provided with Bluetooth technology for facilitated remote monitoring when paired with the SmartView Connect home monitor. These pacemakers will permit cardiologists to monitor the devices remotely, saving patients the necessity to visit a healthcare facility for a simple routine examination and thereby lessening the burden on the healthcare system. Likewise, in April 2021, Smith+Nephew and Huma cooperated in expanding their remote patient monitoring service for orthopedic surgery in the United Kingdom. Also, in January 2022, OMRON Healthcare, Inc. rolled out Hypertension Plus in the United Kingdom. The new remote patient monitoring service has connected blood pressure monitors and a cutting-edge mobile app.
Moreover, in April 2022, Eseye introduced Telli Health's innovative scope of remote patient monitoring (RPM) devices, such as a thermometer, pulse oximeter, blood pressure monitor, and blood glucometer, in the United Kingdom. Additionally, in April 2020, the company released its Rapid Equipment Deployment Kit for intensive care unit (ICU) ramp-ups, allowing technicians, nurses, doctors, and hospital staff to rapidly help critical care patient monitoring capabilities in the COVID-19 pandemic. Thus, from the mentioned data, it is estimated that the growing market developments are driving the European remote patient monitoring market during the forecast period.
The ethical concerns about remote patient monitoring is restraining the growth of Europe’s remote patient monitoring market.
However, ethical concerns are expected to restrain Europe's remote patient monitoring market during the forecast period. For instance, the collection, transfer, and storage of large amounts of health data involved in remote monitoring require careful consideration of privacy and data security concerns. To adequately balance clinical utility with privacy can reduce patients' confidence in remote monitoring and could represent ethical and medicolegal risks for clinicians. Thus, restraining the market growth during the forecast period.
COVID-19 Impact.
The COVID-19 pandemic positioned tremendous pressure on the healthcare system, which was previously low on staff and overburdened. Patient monitoring technologies, like ventilators, aided in monitoring severely ill COVID-19 patients, permitting measurements of physiological reserves and revealing the effectiveness of therapeutic interventions throughout the pandemic, thereby having an advantageous market impact. Furthermore, the firms raised their production of critical/essential medical equipment products. For instance, in March 2020, Royal Philips boosted the production of critical care products and solutions to identify and treat COVID-19 patients. Patient critical signs monitors, medical consumables for non-invasive and invasive ventilation, and portable ventilators to treat respiratory diseases are all part of the product line.
Segment Analysis
The diabetic remote patient monitoring segment will dominate Europe’s remote patient monitoring market during the forecast period (2023-2030).
The diabetic remote patient monitoring segment will dominate the European remote patient monitoring market throughout the forecast period, owing to the growing geriatric populations and diabetic patient pool in Europe. For instance, According to the Eurostat, in 2021, more than one-fifth, i.e., 20.8 %, of the EU population was aged 65 and over, and the percentage of people was 80 or over. The EU's population is anticipated to increase two-and-a-half-fold from 6.0 % in 2021 to 14.6 % in 2100. Also, according to the World Economic Forum, the European Union and other regions across the globe are expected to face rapidly aging populations this century. Across 30% of the EU, the population is predicted to be 65 or older by 2100. In 2021, the EU's dependency ratio was 32, which is expected to reach 57 by 2100, i.e., for every 100 working-age people, there were 57 elderly people.
Moreover, the growing diabetes cases in Europe are also boosting the market growth in the forecast period. For instance, according to the IDF Diabetes Atlas, an estimated 61 million adults were living with diabetes in the IDF Europe Region in 2021, and the region has the most elevated number of adolescents and children with type 1 diabetes, accounting for about 295,000. In addition, according to the WHO Europe, diabetes impacts over 52 million people and a growing percentage of the population in multiple European countries. Furthermore, different market developments in the Europe region for diabetes remote monitoring are ensuring the dominance of diabetes monitoring in the European Diabetes remote monitoring throughout the forecast period.
Geographical Analysis
Germany is expected to hold most of the European remote patient monitoring market.
According to the American Diabetes Association, overweight individuals are at raised risk for type 2 diabetes, heart disease, and stroke. Also the, there is an increased risk for chronic non-communicable disorders such as diabetes and cardiovascular and pulmonary diseases. Therefore, the growing number of overweight individuals and the geriatric population in Germany contributes towards the market growth in this region at an increased CAGR during the forecast period. For instance, according to the Statistisches Bundesamt (Destatis) estimation, the number of people at retirement age (67 years or over) in Germany will rise by roughly 4 million to at least 20.0 million by the middle of the 2030s. The number of those aged 80 or over will remain relatively stable until the middle of the 2030s, amounting to between 5.8 and 6.7 million. In addition, according to the Robert Koch Institute, a Federal Institute within the Federal Ministry of Health's portfolio, two-thirds of men (67%) and half of the women (53%) in Germany are overweight. A quarter of adults (23% of men and 24% of women) are seriously overweight (obese). Thus, the growing geriatric and obese population will ensure the dominance of Germany in the market throughout the forecast period. Thus, from the data mentioned above, it is estimated that Germany holds the majority of Europe's remote patient monitoring market in the projected period.
Competitive Landscape
The Europe remote patient monitoring market is competitive due to the increasing demand ket developments of new market players. The key players operating in the Europe Remote Patient Monitoring market hold most of the market share examples: Abbott Laboratories, GE Healthcare, Medtronic, Masimo Corporation, Boston Scientific, Omron Healthcare, Hill-Rom Services, Inc, BIOTRONIK, Inc., Nihon Kohden Corporation, and Koninklijke Philips N.V. among others. The key players are embracing various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the European Remote Patient Monitoring market. For instance, in April 2020, GE Healthcare launched a new software solution to uphold clinicians and health systems in treating COVID-19 patients.
Medtronic plc.
Overview:
Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronic deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.
Product Portfolio:
Medtronic plcs’ remote patient monitoring product portfolio has Nellcor pulse oximetry: The Nellcor pulse oximetry system with OxiMax technology establishes a new milestone in patient safety monitoring that can impact clinical settings from every day to the extraordinary.
Europe remote patient monitoring report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

상세 목차

Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing Geriatric Population and Associated Chronic Diseases
4.1.1.2. Market Developments
4.1.2. Restraints
4.1.2.1. Ethical Concerns Associated with Data Collection, Storage and Distribution
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Devices
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.3. Services & Software
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Cardiovascular Diseases
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.3. Neurological Disorders
8.4. Respiratory Disorders
8.5. Cancer
8.6. Diabetes
8.7. Sleep Disorder
8.8. Weight management and Fitness Monitoring
8.9. Infectious Diseases
9. By End Users
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
9.1.2. Market Attractiveness Index, By End Users
9.2. Home Care Settings
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
9.3. Hospital/Clinics
9.4. Others
10. By Country
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Country
10.1.2. Market Attractiveness Index, By Country
10.2. Germany
10.2.1. Introduction
10.2.2. Key Country-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
10.3. U.K.
10.3.1. Introduction
10.3.2. Key Country-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
10.4. France
10.4.1. Introduction
10.4.2. Key Country-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
10.5. Italy
10.5.1. Introduction
10.5.2. Key Country-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
10.6. Spain
10.6.1. Introduction
10.6.2. Key Country-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
10.7. Rest of Europe
10.7.1. Introduction
10.7.2. Key Country-Specific Dynamics
10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
12. Company Profiles
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. GE Healthcare
12.3. Medtronic
12.4. Masimo Corporation
12.5. Boston Scientific
12.6. Omron Healthcare
12.7. Hill-Rom Services, Inc
12.8. BIOTRONIK, Inc.
12.9. Nihon Kohden Corporation
12.10. Koninklijke Philips N.V.
LIST NOT EXHAUSTIVE
13. DataM
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us

언급된 주요 기업들

Abbott Laboratories, GE Healthcare, Medtronic, Masimo Corporation, Boston Scientific, Omron Healthcare, Hill-Rom Services, Inc, BIOTRONIK, Inc., Nihon Kohden Corporation, Koninklijke Philips N.V.

표 목록 (Tables)

List of Tables

Table No. 1 Europe Remote Patient Monitoring Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table No. 2 Europe Remote Patient Monitoring Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table No. 3 Europe Remote Patient Monitoring Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table No. 4 Europe Remote Patient Monitoring Market Value, By Country, 2022, 2026 & 2030 (US$ Million)

Table No. 5 Europe Remote Patient Monitoring Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table No. 6 Europe Remote Patient Monitoring Market Value, By Product Type, 2021-2030 (US$ Million)

Table No. 7 Europe Remote Patient Monitoring Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table No. 8 Europe Remote Patient Monitoring Market Value, By Application, 2021-2030 (US$ Million)

Table No. 9 Europe Remote Patient Monitoring Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table No. 10 Europe Remote Patient Monitoring Market Value, By End User, 2021-2030 (US$ Million)

Table No. 11 Europe Remote Patient Monitoring Market Value, By Country, 2022, 2026 & 2030 (US$ Million)

Table No. 12 Europe Remote Patient Monitoring Market Value, By Country, 2021-2030 (US$ Million)

Table No. 13 Germany Remote Patient Monitoring Market Value, By Product Type, 2021-2030 (US$ Million)

Table No. 14 Germany Remote Patient Monitoring Market Value, By Application, 2021-2030 (US$ Million)

Table No. 15 Germany Remote Patient Monitoring Market Value, By End User, 2021-2030 (US$ Million)

Table No. 16 U.K. Remote Patient Monitoring Market Value, By Product Type, 2021-2030 (US$ Million)

Table No. 17 U.K. Remote Patient Monitoring Market Value, By Application, 2021-2030 (US$ Million)

Table No. 18 U.K. Remote Patient Monitoring Market Value, By End User, 2021-2030 (US$ Million)

Table No. 19 France Remote Patient Monitoring Market Value, By Product Type, 2021-2030 (US$ Million)

Table No. 20 France Remote Patient Monitoring Market Value, By Application, 2021-2030 (US$ Million)

Table No. 21 France Remote Patient Monitoring Market Value, By End User, 2021-2030 (US$ Million)

Table No. 22 Italy Remote Patient Monitoring Market Value, By Product Type, 2021-2030 (US$ Million)

Table No. 23 Italy Remote Patient Monitoring Market Value, By Application, 2021-2030 (US$ Million)

Table No. 24 Italy Remote Patient Monitoring Market Value, By End User, 2021-2030 (US$ Million)

Table No. 25 Spain Remote Patient Monitoring Market Value, By Product Type, 2021-2030 (US$ Million)

Table No. 26 Spain Remote Patient Monitoring Market Value, By Application, 2021-2030 (US$ Million)

Table No. 27 Spain Remote Patient Monitoring Market Value, By End User, 2021-2030 (US$ Million)

Table No. 28 Rest of Europe Remote Patient Monitoring Market Value, By Product Type, 2021-2030 (US$ Million)

Table No. 29 Rest of Europe Remote Patient Monitoring Market Value, By Application, 2021-2030 (US$ Million)

Table No. 30 Rest of Europe Remote Patient Monitoring Market Value, By End User, 2021-2030 (US$ Million)

Table No. 31 Abbott Laboratories: Overview

Table No. 32 Abbott Laboratories: Product Portfolio

Table No. 33 Abbott Laboratories: Key Developments

Table No. 34 GE Healthcare: Overview

Table No. 35 GE Healthcare: Product Portfolio

Table No. 36 GE Healthcare: Key Developments

Table No. 37 Medtronic: Overview

Table No. 38 Medtronic: Product Portfolio

Table No. 39 Medtronic: Key Developments

Table No. 40 Masimo Corporation: Overview

Table No. 41 Masimo Corporation: Product Portfolio

Table No. 42 Masimo Corporation: Key Developments

Table No. 43 Boston Scientific: Overview

Table No. 44 Boston Scientific: Product Portfolio

Table No. 45 Boston Scientific: Key Developments

Table No. 46 Omron Healthcare: Overview

Table No. 47 Omron Healthcare: Product Portfolio

Table No. 48 Omron Healthcare: Key Developments

Table No. 49 Hill-Rom Services, Inc: Overview

Table No. 50 Hill-Rom Services, Inc: Product Portfolio

Table No. 51 Hill-Rom Services, Inc: Key Developments

Table No. 52 BIOTRONIK, Inc.: Overview

Table No. 53 BIOTRONIK, Inc.: Product Portfolio

Table No. 54 BIOTRONIK, Inc.: Key Developments

Table No. 55 Nihon Kohden Corporation: Overview

Table No. 56 Nihon Kohden Corporation: Product Portfolio

Table No. 57 Nihon Kohden Corporation: Key Developments

Table No. 58 Koninklijke Philips N.V.: Overview

Table No. 59 Koninklijke Philips N.V.: Product Portfolio

Table No. 60 Koninklijke Philips N.V.: Key Developments

그림 목록 (Figures)

List of Figures

Figure No. 1 Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 2 Europe Remote Patient Monitoring Market Share, By Product Type, 2022 & 2030 (%)

Figure No. 3 Europe Remote Patient Monitoring Market Share, By Application, 2022 & 2030 (%)

Figure No. 4 Europe Remote Patient Monitoring Market Share, By End User, 2022 & 2030 (%)

Figure No. 5 Europe Remote Patient Monitoring Market Share, By Country, 2022 & 2030 (%)

Figure No. 6 Europe Remote Patient Monitoring Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure No. 7 Devices: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 8 Services & Software: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 9 Europe Remote Patient Monitoring Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure No. 10 Cardiovascular Diseases: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 11 Neurological Disorders: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 12 Respiratory Disorders: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 13 Cancer: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 14 Diabetes: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 15 Sleep Disorder: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 16 Weight Management and Fitness Monitoring: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 17 Infectious Diseases: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 18 Europe Remote Patient Monitoring Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure No. 19 Home Care Settings: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 20 Hospital/Clinics: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 21 Others: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 22 Europe Remote Patient Monitoring Market Y-o-Y Growth, By Country, 2022-2030 (%)

Figure No. 23 Germany: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 24 Italy: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 25 France: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 26 U.K.: Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 28 Spain Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 28 Rest of Europe Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 28 Germany Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 29 Germany Remote Patient Monitoring Market Share, By Product Type, 2022 & 2030 (%)

Figure No. 30 Germany Remote Patient Monitoring Market Share, By Application, 2022 & 2030 (%)

Figure No. 31 Germany Remote Patient Monitoring Market Share, By End User, 2022 & 2030 (%)

Figure No. 32 U.K. Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 33 U.K. Remote Patient Monitoring Market Share, By Product Type, 2022 & 2030 (%)

Figure No. 34 U.K. Remote Patient Monitoring Market Share, By Application, 2022 & 2030 (%)

Figure No. 35 U.K. Remote Patient Monitoring Market Share, By End User, 2022 & 2030 (%)

Figure No. 36 France Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 37 France Remote Patient Monitoring Market Share, By Product Type, 2022 & 2030 (%)

Figure No. 38 France Remote Patient Monitoring Market Share, By Application, 2022 & 2030 (%)

Figure No. 39 France Remote Patient Monitoring Market Share, By End User, 2022 & 2030 (%)

Figure No. 40 Italy Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 41 Italy Remote Patient Monitoring Market Share, By Product Type, 2022 & 2030 (%)

Figure No. 42 Italy Remote Patient Monitoring Market Share, By Application, 2022 & 2030 (%)

Figure No. 43 Italy Remote Patient Monitoring Market Share, By End User, 2022 & 2030 (%)

Figure No. 44 Spain Remote Patient Monitoring Market Value, 2021-2030 (US$ Million)

Figure No. 45 Spain Remote Patient Monitoring Market Share, By Product Type, 2022 & 2030 (%)

Figure No. 46 Spain Remote Patient Monitoring Market Share, By Application, 2022 & 2030 (%)

Figure No. 47 Spain Remote Patient Monitoring Market Share, By End User, 2022 & 2030 (%)

Figure No. 48 Rest of Europe Remote Patient Monitoring Market Share, By Product Type, 2022 & 2030 (%)

Figure No. 49 Rest of Europe Remote Patient Monitoring Market Share, By Application, 2022 & 2030 (%)

Figure No. 50 Rest of Europe Remote Patient Monitoring Market Share, By End User, 2022 & 2030 (%)

Figure No. 51 Abbott Laboratories: Financials

Figure No. 52 GE Healthcare: Financials

Figure No. 53 Medtronic: Financials

Figure No. 54 Masimo Corporation: Financials

Figure No. 55 Boston Scientific: Financials

Figure No. 56 Omron Healthcare: Financials

Figure No. 57 Hill-Rom Services, Inc: Financials

Figure No. 58 BIOTRONIK, Inc.: Financials

Figure No. 59 Nihon Kohden Corporation: Financials

Figure No. 60 Koninklijke Philips N.V.: Financials